United States Begins Distribution of Third COVID-19 Vaccine

United States Begins Distribution of Third COVID-19 Vaccine

Doses of the new Johnson & Johnson vaccine could be received as early as March 2.

The Johnson & Johnson vaccine was approved for emergency use authorization by the Federal Drug Administration over the weekend and the process of distributing the vaccine around the country has already begun.

Nearly 3.9 million doses of the J&J vaccine will be distributed to states around the country, a senior Biden administration official said on Sunday. The doses could be delivered as early as Tuesday morning.

The J&J vaccine has shown a 72 percent efficacy rate against mild to severe/critical disease amount U.S. trial participants. It is more effective against severe forms of disease, with about 85 percent protection.

Health experts say Americans should not be deterred by J&J's slightly lower numbers. Its vaccine was tested later than the other two vaccines, when infections were already surging and new variant strains were spreading more widely.

There are advantages to the new J&J vaccine. The vaccine requires the recipient to have to take just one shot, rather than have to return for a second dose at a later time.

In addition to the convenient distribution method, the vaccine does not need to be kept in a freezer and can be stored at refrigerated temperatures.

The single-dose shot comes at a critical time in this pandemic. The country had been in a steady decline of cases for weeks, but the numbers have since plateaued, leaving experts to wonder if highly contagious variants could take hold of U.S. citizens, making the path to victory against this pandemic more lengthy and chaotic.

Dr. Eric Rubin, a professor at the Harvard T.H. Chan School of Public Health described America’s COVID-19 situation as urgent.

“Because there are new viral variants coming out right now, with some chance that some of them could eventually become somewhat resistant to the protection provided by vaccines it is really important to get [the J&J vaccine] out there fast,” Dr. Rubin said.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2022

    June 2022


      Corporate Safety Culture Is Workplace Culture
      Keeping Workers Safe from Heat-Related Illnesses & Injuries
      Should Employers Consider Oral Fluid Drug Testing?
      Addressing Physical Differences
    View This Issue